Study links Ozempic use to potential organ damage risks

A new study suggests that GLP-1 drugs, including Ozempic, may increase the risk of kidney, pancreas, and digestive issues. Researchers analyzed health data from over 2 million military veterans with type 2 diabetes, comparing those on GLP-1s to those on traditional medications. The study found links between GLP-1 use and conditions like pancreatitis and kidney stones, along with confirmed risks of nausea and vomiting. However, it also noted potential benefits, such as lower risks of addiction and improved brain health. Experts caution that the study's observational nature limits its conclusions. They emphasize the need for further research, particularly due to the study's focus on older white males. The findings were published in Nature Medicine.